Marilena Vrana: Take Our New Global Survey on Patient Experiences with Plasma-Derived Medicines
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”Plasma Powers Possibility and Listening Powers Progress.
I’m proud to share a new global survey focused on the voices of patients who rely on plasma-derived medicines.
Building on the strong engagement across the global community in the 2025 International Plasma Awareness Week (IPAW), this is an opportunity to keep that momentum going.
Understanding awareness, experiences, and perceptions will help strengthen education and advocacy worldwide.
If you are a patient, caregiver, or healthcare professional, your voice matters!
Please take 5 minutes to complete the survey and share it with your network.
Every response makes a difference.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator